EMERALD MUTUAL FUND ADVISERS TRUST - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
EMERALD MUTUAL FUND ADVISERS TRUST ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$4,500,000
-73.9%
223,213
-51.7%
0.16%
-72.3%
Q2 2021$17,236,000
+45.2%
461,846
-0.5%
0.56%
+43.1%
Q1 2021$11,871,000
+16.6%
464,258
+0.5%
0.39%
+11.3%
Q4 2020$10,177,000
+60.8%
461,958
+31.3%
0.35%
+26.0%
Q3 2020$6,330,000
-28.3%
351,869
+1.3%
0.28%
-32.6%
Q2 2020$8,824,000
-0.3%
347,411
-27.9%
0.42%
-24.9%
Q1 2020$8,854,000
-39.2%
482,001
-27.1%
0.56%
-6.7%
Q4 2019$14,563,000
+30.3%
661,052
-15.1%
0.60%
+20.2%
Q3 2019$11,179,000
-15.9%
778,516
-7.7%
0.50%
-6.2%
Q2 2019$13,291,000
+1.8%
843,895
-5.3%
0.53%
+0.8%
Q1 2019$13,060,000
+35.2%
891,488
-1.3%
0.52%
+16.2%
Q4 2018$9,658,000
-30.4%
903,439
-0.6%
0.45%
-3.8%
Q3 2018$13,875,000
+115.0%
909,220
+72.6%
0.47%
+100.4%
Q2 2018$6,454,000
+345.4%
526,859
+247.6%
0.23%
+310.5%
Q1 2018$1,449,000
-71.9%
151,571
-73.4%
0.06%
-72.2%
Q4 2017$5,155,000
+195.6%
570,861
+356.7%
0.20%
+51.9%
Q2 2015$1,744,000
+43.8%
125,000
+129.0%
0.14%
+36.4%
Q1 2015$1,213,000
+141.6%
54,584
+79.0%
0.10%
+125.0%
Q4 2014$502,00030,4900.04%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,355,392$29,859,0006.21%
Bain Capital Life Sciences Investors, LLC 3,080,237$67,858,0004.26%
DAFNA Capital Management LLC 587,756$12,948,0003.85%
SILVERARC CAPITAL MANAGEMENT, LLC 227,388$5,009,0002.91%
RTW INVESTMENTS, LP 7,253,857$159,802,0002.68%
Parkman Healthcare Partners LLC 331,513$7,303,0001.87%
Evolutionary Tree Capital Management, LLC 60,864$1,341,0001.02%
Eagle Health Investments LP 69,000$1,520,0000.97%
Woodline Partners LP 1,358,796$29,934,0000.79%
Affinity Asset Advisors, LLC 40,000$881,0000.47%
View complete list of DICERNA PHARMACEUTICALS INC shareholders